David Setboun - Net Worth and Insider Trading
David Setboun Net Worth
The estimated net worth of David Setboun is at least $4,327 dollars as of 2024-11-13. David Setboun is the EVP and COO of Brainstorm Cell Therapeutics Inc and owns about 3,667 shares of Brainstorm Cell Therapeutics Inc (BCLI) stock worth over $4,327. Details can be seen in David Setboun's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that David Setboun has not made any transactions after 2020-07-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of David Setboun
David Setboun Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David Setboun owns 1 companies in total, including Brainstorm Cell Therapeutics Inc (BCLI) .
Click here to see the complete history of David Setboun’s form 4 insider trades.
Insider Ownership Summary of David Setboun
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BCLI | Brainstorm Cell Therapeutics Inc | 2020-07-16 | EVP and COO |
David Setboun Latest Holdings Summary
David Setboun currently owns a total of 1 stock. David Setboun owns 3,667 shares of Brainstorm Cell Therapeutics Inc (BCLI) as of July 16, 2020, with a value of $4,327.
Latest Holdings of David Setboun
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BCLI | Brainstorm Cell Therapeutics Inc | 2020-07-16 | 3,667 | 1.18 | 4,327 |
Holding Weightings of David Setboun
David Setboun Form 4 Trading Tracker
According to the SEC Form 4 filings, David Setboun has made a total of 1 transactions in Brainstorm Cell Therapeutics Inc (BCLI) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Brainstorm Cell Therapeutics Inc is the acquisition of 333 shares on July 16, 2020, which cost David Setboun around $64,750.
Insider Trading History of David Setboun
- 1
David Setboun Trading Performance
GuruFocus tracks the stock performance after each of David Setboun's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by David Setboun is 3.2%. GuruFocus also compares David Setboun's trading performance to market benchmark return within the same time period. The performance of stocks bought by David Setboun within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how David Setboun's insider trading performs compared to the benchmark.
Performance of David Setboun
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -1.19 | | | | | |
| Relative Return to S&P 500(%) | -6.08 | | | | | |
David Setboun Ownership Network
Ownership Network List of David Setboun
Ownership Network Relation of David Setboun
David Setboun Owned Company Details
What does Brainstorm Cell Therapeutics Inc do?
Who are the key executives at Brainstorm Cell Therapeutics Inc?
David Setboun is the EVP and COO of Brainstorm Cell Therapeutics Inc. Other key executives at Brainstorm Cell Therapeutics Inc include Chief Executive Officer Chaim Lebovits , EVP & Head Global Clin Research Stacy Lindborg , and Chief Medical Officer Kirk Taylor .
Brainstorm Cell Therapeutics Inc (BCLI) Insider Trades Summary
Over the past 18 months, David Setboun made no insider transaction in Brainstorm Cell Therapeutics Inc (BCLI). Other recent insider transactions involving Brainstorm Cell Therapeutics Inc (BCLI) include a net purchase of 590,208 shares made by Chaim Lebovits , a net sale of 63,000 shares made by , and a net purchase of 11,500 shares made by Stacy Lindborg .
In summary, during the past 3 months, insiders sold 0 shares of Brainstorm Cell Therapeutics Inc (BCLI) in total and bought 23,836 shares, with a net purchase of 23,836 shares. During the past 18 months, 4,200 shares of Brainstorm Cell Therapeutics Inc (BCLI) were sold and 62,361 shares were bought by its insiders, resulting in a net purchase of 58,161 shares.
Brainstorm Cell Therapeutics Inc (BCLI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Brainstorm Cell Therapeutics Inc Insider Transactions
David Setboun Mailing Address
Above is the net worth, insider trading, and ownership report for David Setboun. You might contact David Setboun via mailing address: C/o Brainstorm Cell Therapeutics, Inc., 1325 Avenue Of Americas, 28th Floor, New York Ny 10019.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
